English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 903857 Online Users : 650
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
Scope
All of NHRI
感染症與疫苗研究所
劉士任
--會議論文/會議摘要
Tips:
please add "double quotation mark" for query phrases to get precise results
please goto advance search for comprehansive author search
Adv. Search
Home
‧
Login
‧
Upload
‧
Help
‧
About
‧
Administer
國家衛生研究院 NHRI
>
感染症與疫苗研究所
>
劉士任
>
會議論文/會議摘要
>
Browse By Title
Browse By Authors
Browse By Date
Browse By Data Type
Loading...
Siblings
圖書
[
1
/1]
專利
[
0
/24]
期刊論文
[
110
/113]
Collection Statistics
近3年內發表的文件:1(9.09%)
含全文筆數:10(90.91%)
文件下載次數統計
下載大於0次:10(100.00%)
下載大於100次:10(100.00%)
檔案下載總次數:4484(6.63%)
最後更新時間: 2024-12-01 06:33
Top Upload
Loading...
Top Download
Loading...
Recent Submissions
ADAM9 drives immunosuppressive envi...
Synthetic peptide of tumour-associa...
ADAM9 as a target for lung cancer t...
Efficient uptake of recombinant lip...
Cross-presentation of lipidated and...
Gemcitabine synergistically enhance...
Chemotherapy enhances recombinant l...
Depletion of tumor-associated macro...
Improvement of cell capture efficie...
Arrayed specific t-cell monitor via...
Jump to a point in the index:
(Choose year)
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1985
1980
1975
1970
1960
1950
(Choose month)
January
February
March
April
May
June
July
August
September
October
November
December
Or type in a year:
Ordering With Most Recent First
Show Oldest First
Showing items 1-11 of 11. (1 Page(s) Totally)
1
View [
10
|
25
|
50
] records per page
Date
Title
Relation
2023-05-01
ADAM9 drives immunosuppressive environment for lung tumor progression
Journal of Immunology. 2023 May 01;210(Suppl. 1):Abstract number 172.08.
2019-10
ADAM9 as a target for lung cancer treatment
Annals of Oncology. 2019 Oct;30(Suppl. 5):788.
2019-10
Synthetic peptide of tumour-associated antigen L6 formulated with polymer-based adjuvant enhances anti-tumour effects in mice
Annals of Oncology. 2019 Oct;30(Suppl. 5):23.
2018-10
Efficient uptake of recombinant lipidated survivin by antigen-presenting cells initiates antigen cross-presentation and antitumor immunity
Journal of Thoracic Oncology. 2018 Oct;13(10, Suppl.):S526.
2018-05
Cross-presentation of lipidated and non-lipidated synthetic peptide
European Journal of Immunology. 2018 May;48(Suppl. 1):36.
2015-11
Gemcitabine synergistically enhances anti-tumor effects of recombinant immunogen-based cancer immunotherapy
Annals of Oncology. 2015 Nov;26(Suppl. 7):vii79-vii105.
2014-10
Chemotherapy enhances recombinant lipoimmunogen-based antitumor immunity against cervical cancer
Cancer Research. 2014 Oct;74(19 Suppl.):Abstract No. 637.
2014-07
Depletion of tumor-associated macrophages enhances peptide-based cancer immunotherapy
European Journal of Cancer. 2014 Jul;50(Suppl. 5):S215.
2009-06
Improvement of cell capture efficiency using a reversible DEP field
TRANSDUCERS 2009 - 15th International Conference on Solid-State Sensors, Actuators and Microsystems. 2009 Jun:1782-1785(Article number 5285719).
2008-10
Arrayed specific t-cell monitor via immuno-capture under weak-DEP enhancement
2008 IEEE Sensors. 2008 Oct:235-238(Article number 4716424).
2007-07
Induction of a distinct CD8 TNC17 subset by transforming growth factor-beta and interleukin-6
Cytokine. 2007 Jul;39(1):25.
Showing items 1-11 of 11. (1 Page(s) Totally)
1
View [
10
|
25
|
50
] records per page
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
Feedback